Skip to main content
Saniona logo

Saniona — Investor Relations & Filings

Ticker · SANION ISIN · SE0005794617 LEI · 549300XO4L9XNOCFCZ84 ST Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2024-01-16 Earnings Release
Country SE Sweden
Listing ST SANION

About Saniona

http://saniona.com

Saniona is a clinical-stage biopharmaceutical company focused on the research and development of treatments for neurological disorders, with a primary emphasis on epilepsy. The company is a leader in the field of ion channel modulation, leveraging its expertise and a proprietary drug discovery engine to create new medicines. Saniona has developed an extensive library of over 20,000 proprietary molecules designed to target various ion channels. Its pipeline includes multiple potential new medicines advancing through clinical trials, with the goal of addressing unmet medical needs for patients with central nervous system diseases.

Recent filings

Filing Released Lang Actions
Saniona meddelar preliminära finansiella siffror för 2023
Earnings Release Classification · 100% confidence The document is a press release titled 'Saniona meddelar preliminära finansiella siffror för 2023' (Saniona announces preliminary financial figures for 2023). It provides key financial highlights (revenue, cash position) and discusses business updates, including a rights issue and clinical pipeline progress. While it contains financial data, it is an initial announcement of preliminary results rather than a full quarterly or annual report. According to the 'Menu vs Meal' rule, since it is a press release announcing preliminary figures and explicitly mentions that the full 'Bokslutskommunikén' (Year-end report) will be published later, it is classified as an Earnings Release (ER). Q4 2023
2024-01-16 Swedish
Kommuniké från extra bolagsstämma den 16 januari 2024 i Saniona AB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release titled 'Kommuniké från extra bolagsstämma' (Communiqué from the Extraordinary General Meeting) for Saniona AB. It details the decisions made during the meeting, such as amendments to the articles of association, approval of a rights issue, and various board authorizations. While it reports on the meeting's outcomes, it is structured as a formal announcement of the meeting's results. According to the provided definitions, documents detailing the results of shareholder votes at general meetings are classified as DVA (Declaration of Voting Results & Voting Rights Announcements).
2024-01-16 Swedish
Bulletin from the Saniona AB extraordinary shareholders’ meeting on January 16, 2024
AGM Information Classification · 98% confidence The document is a press release titled 'Bulletin from the Saniona AB extraordinary shareholders' meeting'. It details the resolutions passed at an extraordinary general meeting, including amendments to the Articles of Association and approvals for a rights issue of units (shares and warrants). While it contains information about voting results, it is primarily a summary of the meeting's outcomes and corporate actions. According to the provided definitions, documents detailing the results of shareholder votes at general meetings are classified as DVA (Declaration of Voting Results & Voting Rights Announcements).
2024-01-16 English
Saniona offentliggör slutliga villkor i företrädesemission
Capital/Financing Update Classification · 100% confidence The document is a press release from Saniona AB announcing the final terms of a rights issue (företrädesemission). It details the subscription price, the number of shares and warrants to be issued, the subscription period, and the use of proceeds. It also includes information on subscription commitments and lock-up agreements. This is a classic capital raising announcement, which falls under the 'Capital/Financing Update' category.
2024-01-10 Swedish
Saniona announces final terms of rights issue
Capital/Financing Update Classification · 100% confidence The document is a press release from Saniona AB announcing the final terms of a rights issue (a capital raise). It details the subscription price, the number of shares/warrants to be issued, the subscription period, and the use of proceeds. While it mentions an upcoming prospectus, the document itself is the primary announcement of the financing terms, which fits the definition of a Capital/Financing Update (CAP).
2024-01-10 English
Saniona advances SAN2465 as a novel rapid-onset clinical candidate for major depressive disorder
Regulatory Filings Classification · 95% confidence The document is a press release issued by Saniona regarding the advancement of a clinical candidate (SAN2465). It details scientific findings, quotes from management, and provides background on the company's pipeline. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement (RPA) as it contains substantive news content. Therefore, it is classified as a general regulatory filing (RNS) under the Market Abuse Regulation.
2024-01-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.